Apeloa Pharmaceutical Co.,Ltd
000739
Rankning i aktier
#4306
Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical... Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical enterprise, specializing in the discovery, development, production, and global distribution of a diverse range of medicinal products. Its market reach spans China and various international territories. The company strategically focuses its product portfolio on several critical medical fields, including cardiovascular and cerebrovascular health, anti-infective treatments, antiviral therapies, and oncology (cancer treatment), alongside other therapeutic categories. Apeloa's offerings encompass finished pharmaceutical preparations, raw material intermediates (active pharmaceutical ingredients and their precursors), and veterinary medicines. These products are primarily recognized and sold under key brands such as Tianliwei, Beshin, Yosemade, and Jutai, among others. Furthermore, the company extends its expertise to other pharmaceutical businesses by providing contract research, development, and manufacturing (CDMO) services. The corporate headquarters for Apeloa Pharmaceutical Co.,Ltd are located in Dongyang, China.
Aktiekurs
$3.17
Senast synkroniserad: 2026-10-21
Marknadsvärde
$3.67B
Förändring (1 dag)
0.76%
Förändring (1 år)
48.70%
Land
CN
Handel Apeloa Pharmaceutical Co.,Ltd (000739)
Kategori
Healthcare
Utdelningsavkastning för Apeloa Pharmaceutical Co.,Ltd (000739)
Utdelningsavkastningen (TTM) för Apeloa Pharmaceutical Co.,Ltd (aktiesymbol: 000739) per 2023-12-31 är: 2.11%
Genomsnittlig utdelningsavkastning de senaste 5 åren: 1.39%
Genomsnittlig utdelningsavkastning de senaste 5 åren: 1.39%
Historik för utdelningsavkastning för Apeloa Pharmaceutical Co.,Ltd (000739) från 2000 till 2026
Utdelningsavkastning i slutet av varje år (TTM)
| År | Utdelningsavkastning | Ändra |
|---|---|---|
| 2026 (TTM) | 1.58% | -25.82% |
| 2024 | 2.13% | 0.95% |
| 2023 | 2.11% | 58.65% |
| 2022 | 1.33% | 92.75% |
| 2021 | 0.69% | -2.82% |
| 2020 | 0.71% | -16.47% |
| 2019 | 0.85% | -37.96% |
| 2018 | 1.37% | -27.51% |
| 2017 | 1.89% | 26.00% |
| 2016 | 1.50% | -13.29% |
| 2015 | 1.73% | 61.68% |
| 2014 | 1.07% | -43.68% |
| 2013 | 1.90% | -63.60% |
| 2012 | 5.22% | 338.66% |
| 2011 | 1.19% | -10.53% |
| 2010 | 1.33% | -8.90% |
| 2009 | 1.46% | -60.96% |
| 2008 | 3.74% | 128.05% |
| 2007 | 1.64% | -45.15% |
| 2006 | 2.99% | -43.58% |
| 2005 | 5.30% | 46.81% |
| 2004 | 3.61% | 37.79% |
| 2003 | 2.62% | 12.93% |
| 2002 | 2.32% | 286.67% |
| 2001 | 0.60% | 81.82% |
| 2000 | 0.33% | 0.00% |
Utdelningsavkastning (TTM) för liknande företag eller konkurrenter
| Företag | Utdelningsavkastning | Land |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
